Haitao Zhao

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Large-scale prediction of long non-coding RNA functions in a coding–non-coding gene co-expression network

Qi Liao, Changning Liu, Xiongying Yuan et al. · Nucleic Acids Research · 2011 · 605 citations · Full text

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma

Junyu Long, Anqiang Wang, Yi Bai et al. · EBioMedicine · 2019 · 427 citations · Full text

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers

Zhen Yang, Liangcai Wu, Anqiang Wang et al. · Nucleic Acids Research · 2016 · 348 citations · Full text